Horizon Therapeutics plc

11/22/2021 | Press release | Distributed by Public on 11/22/2021 07:11

New Analysis Published in Multiple Sclerosis and Related Disorders Supports the Efficacy of UPLIZNA® (inebilizumab-cdon) in Patients Previously Treated with Rituximab for[...]